The pod was received with no evidence of blood on the device.Investigation results found no evidence of any damage or manufacturing deficiencies that would cause bleeding, bruising, or swelling at the infusion site.The exact cause of the reported swelling could not be determined.The device was received with the soft cannula deployed.Corrosion was observed on the pcb assembly, all three batteries, and the catch beam.Due to the corrosion, the bottom and middle battery voltages were measured to be lower than expected.Fluid path testing found a tear on the unexposed portion of the soft cannula which resulted in an internal leak.This leak prevented the proper delivery of insulin.Lot release records were reviewed and the product lot met all acceptance criteria.Specifically, a pod is paired to a pdm and put through simulated use testing including confirming the blue soft cannula is inspected for any damage.
|